ISSN: 0300-8932 Factor de impacto 2023 7,2
Vol. 5. Núm. C.
Páginas 1C-7C (Agosto 2005)

Manejo del síndrome coronario agudo
Introducción: puntos clave en el manejo del síndrome coronario agudo sin elevación del segmento ST

Héctor Bueno¿

Opciones

Este artículo solo puede leerse en pdf
Bibliografía
[1.]
H. Bueno.
Síndromes coronarios agudos: entre la confusión y la claridad terminological.
Cardiología Práctica, (2002), 11 pp. 1-3
[2.]
E.B. Sgarbossa, S.L. Pinski, A. Barbagelata, D.A. Underwood, K.B. Gates, E.J. Topol, et al.
Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block.
N Engl J Med, (1996), 334 pp. 481-487
[3.]
U. Stenestrand, F. Tabrizi, J. Lindback, A. Englund, M. Rosenqvist, L. Wallentin.
Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block.
Circulation, (2004), 110 pp. 1896-1902
[4.]
The Joint European Society of Cardiology/American College of Cardiology Committee.
Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction.
Eur Heart J, (2000), 21 pp. 1502-1513
[5.]
E.M. Antman, M. Cohen, P.J. Bernink, C.H. McCabe, T. Horacek, G. Papuchis, et al.
The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making.
JAMA, (2000), 284 pp. 835-842
[6.]
K.A. Eagle, M.J. Lim, O.H. Dabbous, K.S. Pieper, R.J. Goldberg, F. Van de Werf, et al.
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.
JAMA, (2004), 291 pp. 2727-2733
[7.]
L. López Bescós, F. Arós Borau, R.M. Lidón Corbi, A. Cequier Fillat, H. Bueno, J.J. Alonso, et al.
Actualización (2002) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en an- gina inestable/infarto sin elevación del segmento ST.
Rev Esp Cardiol, (2002), 55 pp. 631-642
[8.]
M.E. Bertrand, M.L. Simoons, K.A. Fox, L.C. Wallentin, C.W. Hamm, E. McFadden, et al.
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.
Eur Heart J, (2000), 21 pp. 1406-1432
[9.]
M.E. Bertrand, M.L. Simoons, K.A. Fox, L.C. Wallentin, C.W. Hamm, E. McFadden, et al.
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology.
Eur Heart J, (2002), 23 pp. 1809-1840
[10.]
E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J. Hochman, et al.
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
J Am Coll Cardiol, (2000), 36 pp. 970-1062
[11.]
E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J. Hochman, et al.
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
J Am Coll Cardiol, (2002), 40 pp. 1366-1374
[12.]
C.P. Cannon, W.S. Weintraub, L.A. Demopoulos, R. Vicari, M.J. Frey, N. Lakkis, et al.
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
N Engl J Med, (2001), 344 pp. 1879-1887
[13.]
D.A. Morrow, E.M. Antman, M. Tanasijevic, N. Rifai, J.A. De Lemos, C.H. McCabe, et al.
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.
J Am Coll Cardiol, (2000), 36 pp. 1812-1817
[14.]
E. Boersma, R.A. Harrington, D.J. Moliterno, H. White, P. Theroux, F. Van de Werf, et al.
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials.
[15.]
H. Bueno, M. Heras, A. Bardají, A. Fernández-Ortíz, H. Martí, J. Marrugat, et al.
Diabetic patients hospitalised for ACS are not treated more aggresively despite their worse prognosis. Results of the DESCARTES registry.
Eur Heart J, (2004), 25
[16.]
M. Roffi, D.P. Chew, D. Mukherjee, D.L. Bhatt, J.A. White, C. Heeschen, et al.
Platelet glycoprotein iib/iiia inhibitors reduce mortality in diabetic patients with non–st-segment-elevation acute coronary syndromes.
Circulation, (2001), 104 pp. 2767-2771
Copyright © 2005. Sociedad Española de Cardiología
¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?